Amadeus Capital is a global technology investor that invests in technology companies at all stages, from seed to venture buyout; they also buy stakes from other investors or founders, to ensure that companies and entrepreneurs have the runway they need to succeed. They invest in a broad variety of sectors including enterprise and infrastructure software, consumer and business services, medical technology and healthcare IT, and cleantech and resource efficiency. It has the imagination to see where new businesses can be created and the technical insight, operational experience and global network to help entrepreneurs make their vision a reality. The Company was founded in 1997 and since has backed more than 130 companies and raised over $1bn for investment.

Amadeus Capital Partners

IQ Capital is a Cambridge & London-based VC firm that invests in ‘deep tech’ companies capable of dominating their respective markets on a global scale. Initial investments at Seed and Series A range from £0.5m to £10m, with capacity for follow-on investment up to £30m through the Growth Fund. The team has achieved over 30 exits including to Apple, Huawei, Google and Oracle.

IQ Capital

University of Cambridge Enterprise, also known as Cambridge Enterprise Seed Funds, consisting of the Challenge Fund and the Venture Fund, is a resource for members of the University of Cambridge and the Babraham Institute. Investments are priced and structured competitively with other sources of early stage seed capital in order to encourage co-investment, follow-on funding and commercialisation of University of Cambridge and Babraham Institute inventions.

University of Cambridge Enterprise

Martlet Capital is an early-stage investor based in Cambridge, providing patient capital to deep technology and life science startups with high growth potential. They seek to support entrepreneurs with value beyond capital. They have experience of helping companies scale from first-round through to exit. Visit their website to take a look at how we work and their investment focus.

Martlet Capital

Ahren Innovation Capital is an investment institution that supports transformational companies at the intersection of deep tech and deep science that will penetrate, or create, massive markets.  Ahren is a unique partnership of investment talent and best-in-class commercial scientists whose technologies are today valued in excess of $100BN combined. Ahren believes in taking asymmetric, considered, risk that will deliver superior rewards – capturing a generational opportunity to provide smart capital to deep technology. With a philosophy espousing the importance of relationships and trust, Ahren provides both patient and active capital to exceptional founders and teams, empowering them to succeed.

Ahren Innovation Capital

Seraphim Capital is dedicated to financing the growth of companies operating in the space ecosystem. They are an ambitious team with a wide variety of backgrounds and experiences in Venture. Collectively they have over 100 years’ experience, investing in over 180 early and growth stage businesses, returning more than £750 million to their shareholders. They are also fortunate to have one of the world's leading entrepreneurs and experts in Earth Observation on board.  They work closely with their portfolio companies and always strive to create meaningful value and endeavour to ensure that the full value of their network and partners is utilised. The backing of leading global corporates in the Space sector and the leading Space related Governmental Agencies in the UK and Europe brings significant value. They are able to leverage their capital, industry leading knowledge and networks, creating an ecosystem that delivers real results for your business. From roots to market, sales and marketing, partnerships, follow-on capital, and M&A they can deliver value creation across the company growth cycle globally.

Seraphim Space

Parkwalk is a London-based fund management firm.  Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009, anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth. Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow.                                                                                                                 In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Parkwalk Advisors

The University of Cambridge is a public research university based in Cambridge, England. The university has more than 18,000 students, with nearly 9,000 staff members. It is organized into 31 colleges and 150 departments and other institutions. The university is made up of six schools comprising of arts and humanities, biological sciences, clinical medicine, humanities and social sciences, physical sciences, and technology.  The University Cambridge is the wealthiest university in the UK with an endowment of £4.9 billion in 2013, some of which was received as research grants. The university was founded in 1209 and is one of the oldest universities in the world.  The University of Cambridge is rich in history - its famous Colleges and University buildings attract visitors from all over the world. But the University's museums and collections also hold many treasures which give an exciting insight into some of the scholarly activities, both past and present, of the University's academics and students.  The University of Cambridge is one of the world's oldest universities and leading academic centres, and a self-governed community of scholars. Its reputation for outstanding academic achievement is known world-wide and reflects the intellectual achievement of its students, as well as the world-class original research carried out by the staff of the University and the Colleges.

University of Cambridge

Presidio Ventures is the corporate venture capital arm of Sumitomo Corporation, one of the world’s leading integrated trading companies. Presidio helps the technologies of tomorrow secure their place in the global market, offering solid financial support, and expertise in business development. With offices in Silicon Valley and Boston, Presidio Ventures has invested in more than 160 companies over the past twenty years. Presidio's expansive network of Sumitomo affiliates and subsidiaries helps it in tailoring support for start-ups, ensuring that new companies can succeed from early-stage investment all the way to IPO. Presidio looks for opportunities to partner with entrepreneurs in key industries that shape the way people live.

Presidio Ventures

Deeptech Labs is a VC fund, accelerator, and catalyst for deep tech success.

Deeptech Labs

The National Security Strategic Investment Fund is the British Government’s corporate venturing arm for dual-use advanced technologies. It is a joint initiative between HM Government and the British Business Bank. NSSIF invests commercially in advanced technology firms, alongside other investors, supporting long-term equity investment – ‘patient capital’ – and harnesses the Government’s unique technology expertise. Its objectives include accelerating the adoption of HMG’s future national security and defense capabilities and the development of the UK’s dual-use technology ecosystem.

National Security Strategic Investment Fund

Expeditions Fund is a long-term and patient venture capital fund investing in early-stage technology companies globally led by mission-driven founders. The fund has initially started as venture capital operations of Firlej Kastory family office. In 2021, Firlej Kastory expanded beyond immediate family management and the venture capital firm, Expeditions Fund, was created. Expeditions Fund today is an independent venture fund backed by multi-billion dollar investors, family offices, founders and CEOs of successful companies.

Expeditions Fund

Nu Quantum

Nu Quantum is building the quantum networking infrastructure essential to scaling quantum computers, by interconnecting quantum computing cores into large distributed clusters. We are creating full hardware solutions to create entangled qubit networks, including a unique high-speed computer network interface, photonic switching fabric, and control systems to accelerate the roadmap towards multi-core quantum supercomputers and quantum data centres. Partnering with leading QC companies, governments and research groups, we seek to bring this technology to market.

Nu Quantum

Company Brief

Funding

Investors

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless